| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07179380 Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… |
Trial sites expanded: 109 -> 145 locations |
| 2026-08-14 | NCT07234032 An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… |
Recruitment opened |
| 2026-08-14 | NCT07234032 An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… |
Trial sites expanded: 0 -> 9 locations |
| 2026-08-12 | NCT07643155 A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07765706 A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07481981 | A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil… | Pulmonary Arterial Hypertension | Recruiting |
| NCT07234032 | An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… | Pulmonary Hypertension | Recruiting |
| NCT07179380 | Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in… | Pulmonary Hypertension | Recruiting |
| Phase 2/3 | |||
| NCT05649748 | An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary… | Pulmonary Arterial Hypertension | Active, Not Recruiting |
| Phase 1 | |||
| NCT07643155 | A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil… | Hepatic Impairment | Recruiting |
| NCT07765706 | A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in… | Healthy Volunteers | Not Yet Recruiting |